Task: Answer the multiple-choice question.
Question: Which compound exhibits a 1.660% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a COc1cccc(CN2CCN(C(=O)c3cccc(OC)c3)CC2)c1.O=C(O)C(=O)O
b CCOc1ccc(-c2cc(C(=O)N/N=C/c3cccnc3)c3ccccc3n2)cc1
Answer: b. CCOc1ccc(-c2cc(C(=O)N/N=C/c3cccnc3)c3ccccc3n2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCOc1ccc(-c2cc(C(=O)N/N=C/c3cccnc3)c3ccccc3n2)cc1
CCOc1ccc(-c2cc(C(=O)N/N=C/c3cccnc3)c3ccccc3n2)cc1
2-(4-ethoxyphenyl)-N-[(E)-pyridin-3-ylmethylideneamino]quinoline-4-carboxamide